Search

Study calls for thorough investigation of patients with early signs of retinal vascular disease

Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk of heart attacks and strokes may be greater than previously shown, suggests a new study led by researchers at Moorfields Eye Hospital NHS Foundation Trust.

SpaMedica announces partnership with Macular Society

SpaMedica, one of the UK’s leading independent providers of NHS eye care services, is proud to announce a new partnership with the Macular Society, set to launch this month. The collaboration will help to fund ground-breaking research and vital support...

Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals

Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.

Macular Society chief executive, Cathy Yelf, announces retirement

After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.

The friendly face of ophthalmology

The friendly face of ophthalmology

New partnership to prevent unnecessary sight loss

Sight loss charity the Macular Society has announced a new partnership with OcuPlan, a service designed to give patients with long-term eye conditions such as macular disease affordable access to specialist care to prevent unnecessary sight loss.

Obituary: Sohan Singh Hayreh (1927 - 2022)

Sohan would have been 95 on 6 November this year, but due to complications of COVID-19, he passed away on 29 September.

First treatment for late-stage dry AMD rejected by UK drug regulator

Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...

Moorfields earns UK’s first UKAS accreditation for ophthalmic and vision science (IQIPS)

The United Kingdom Accreditation Service (UKAS) has granted the first accreditation for Ophthalmic and Vision Science to Moorfields Eye Hospital. The award was made to the Electrophysiology Department at Moorfields under the Improving Quality In Physical Services (IQIPS) programme.

100% Ophthalmology Programme Insights

We spoke to some of the Eye News family about their upcoming presentations at 100% Opthalmology, 24–26 February 2024, ExCeL London, UK.

All eyes on Twiggy as she fronts new campaign warning us: don’t lose focus of your eye health

Dame Twiggy Lawson fronts a new public awareness campaign focused on eye health, as cases of macular disease increase with our ageing population.

New funding will support development of wearable diagnostics for neuromuscular diseases

A researcher from the University of Glasgow has received an EPSRC Open Fellowship to develop new wearable technology capable of measuring the progress of neuromuscular diseases.